Drug Search Results
More Filters [+]

Prothipendyl

Alternative Names: prothipendyl
Latest Update: 2024-01-09
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: DR Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Belgium | India | Luxembourg

Approved Indications: None

Known Adverse Events: None

Company: Hannover Medical School
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Prothipendyl

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events